Marzia Perluigi

Pubblicazioni

Titolo	Pubblicato in	Anno
Oxidative stress and mTOR in Down syndrome brain: Link to Alzheimer’s dysmetabolism, neuropathology, and possible therapies	FREE RADICAL BIOLOGY & MEDICINE	2021
Protein oxidative damage in UV-related skin cancer and dysplastic lesions contributes to neoplastic promotion and progression	CANCERS	2020
Brain insulin resistance triggers early onset Alzheimer disease in Down syndrome	NEUROBIOLOGY OF DISEASE	2020
The anti-diabetic drug metformin rescues aberrant mitochondrial activity and restrains oxidative stress in a female mouse model of rett syndrome	JOURNAL OF CLINICAL MEDICINE	2020
Potential therapeutic value of the anti-diabetic drug metformin in a mouse model of Rett syndrome: a preclinical study	FENS 2020 virtual forum	2020
Multiple Herpes simplex virus-1 (HSV-1) reactivations induce protein oxidative damage in mouse brain. Novel mechanisms for Alzheimer’s disease progression	MICROORGANISMS	2020
Down syndrome Is a metabolic disease: altered Insulin signaling mediates peripheral and brain dysfunctions	FRONTIERS IN NEUROSCIENCE	2020
Sorcin is an early marker of neurodegeneration, Ca2+ dysregulation and endoplasmic reticulum stress associated to neurodegenerative diseases	CELL DEATH & DISEASE	2020
The BACH1/Nrf2 axis in brain in down syndrome and transition to alzheimer disease-like neuropathology and dementia	ANTIOXIDANTS	2020
Chronic perk induction promotes alzheimer-like neuropathology in down syndrome: Insights for therapeutic intervention	PROGRESS IN NEUROBIOLOGY	2020
Cytosolic serine hydroxymethyltransferase controls lung adenocarcinoma cells migratory ability by modulating AMP kinase activity	CELL DEATH & DISEASE	2020
The dysregulation of OGT/OGA cycle mediates Tau and APP neuropathology in down syndrome	NEUROTHERAPEUTICS	2020
Proteomics study of peripheral blood mononuclear cells in down syndrome children	ANTIOXIDANTS	2020
BVR-A deficiency leads to autophagy impairment through the dysregulation of AMPK/mTOR axis in the brain—Implications for neurodegeneration	ANTIOXIDANTS	2020
Biliverdin reductase-A mediates the beneficial effects of intranasal insulin in Alzheimer disease	MOLECULAR NEUROBIOLOGY	2019
Loss of biliverdin reductase-A favors Tau hyper-phosphorylation in Alzheimer's disease	NEUROBIOLOGY OF DISEASE	2019
Reduced biliverdin reductase-a levels are associated with early alterations of insulin signaling in obesity	BIOCHIMICA ET BIOPHYSICA ACTA. MOLECULAR BASIS OF DISEASE	2019
Restoration of aberrant mTOR signaling by intranasal rapamycin reduces oxidative damage: Focus on HNE-modified proteins in a mouse model of down syndrome	REDOX BIOLOGY	2019
Oxidative stress and inflammation in a spectrum of epileptogenic cortical malformations: molecular insights into their interdependence	BRAIN PATHOLOGY	2019
Targeting mitochondria in Alzheimer disease: rationale and perspectives	CNS DRUGS	2019

Pubblicazioni

Progetti di Ricerca